Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / cs
-
Total 13F shares
-
182,302
-
Share change
-
+157,286
-
Total reported value
-
$179,171
-
Price per share
-
$0.98
-
Number of holders
-
14
-
Value change
-
+$101,129
-
Number of buys
-
7
-
Number of sells
-
3
Institutional Holders of HELIUS MEDICAL TECHNOLOGIES, INC. - cs (HSDT) as of Q2 2024
As of 30 Jun 2024,
HELIUS MEDICAL TECHNOLOGIES, INC. - cs (HSDT) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
182,302 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Tower Research Capital LLC (TRC), UBS Group AG, CoreCap Advisors, LLC, OSAIC HOLDINGS, INC., Federation des caisses Desjardins du Quebec, and American Capital Advisory, LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.